L’immunothérapie intra-tumorale

L’immunothérapie intra-tumorale

Le principe de l’immunothérapie intra-tumorale consiste à utiliser la tumeur comme son propre vaccin en y injectant des produits stimulant l’immunité contre les molécules altérées du cancer.

Sanofi and Gustave Roussy are strengthening their strategic oncology research collaboration

Paris and Villejuif, France – 19th January 2023

Sanofi and Gustave Roussy are strengthening their strategic oncology research collaboration

Sanofi and Gustave Roussy are announcing today new collaborative efforts focussed on three early-phase oncological research projects.

Equipes Sanofi - Gustave Roussy

Pages